V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10366416 | 10069499 | 1.75 | 62.15 | null | 2020-05-23 | 2020-05-24 | Doxorubicin + Olaratumab | 02 | null | RCD TRIAL | 101417409 |
| 10372373 | 10069502 | 1.63 | 0 | null | 2019-01-05 | 2019-06-05 | AVELUMAB + AXITINIB | N | null | CAPECITABINE + NIVOLUMAB + OXALIPLATIN | 100812567 |
| 10381938 | 10069505 | 1.78 | 59.6 | null | 2019-03-14 | 2019-03-15 | DOCETAXEL + TRASTUZUMAB | 01 | null | DOCETAXEL + NINTEDANIB | 101748891 |
| 10384782 | 10069506 | 0 | 72.5 | Palliative (P) | 2018-12-21 | 2019-04-10 | CARBOPLATIN + DOCETAXEL + Pertuzumab + Trastuzumab | 02 | N | DOCETAXEL + GEMCITABINE | 100920432 |
| 10388861 | 10069509 | 1.72 | 69.8 | 03 | 2019-02-26 | 2019-02-26 | NAB PACLITAXEL | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 101616462 |
| 10391097 | 10069511 | 1.59 | 88 | null | 2020-05-14 | 2020-07-09 | PEG INTERFERON | 02 | null | FCR | 101266589 |
| 10406530 | 10069517 | 0 | 51.4 | Palliative (P) | 2018-05-31 | 2018-09-09 | Ipilimumab | 02 | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 100252882 |
| 10407616 | 10069519 | 1.62 | 121.1 | Curative (C) | 2014-07-15 | 2020-01-21 | CARBOPLATIN + FLUOROURACIL | 02 | N | FLUOROURACIL + MITOMYCIN | 100748066 |
| 10407907 | 10069520 | 1.85 | 66 | null | 2019-05-16 | 2019-09-27 | Trial Unspecified | 02 | null | BCG | 100734335 |
| 10410681 | 10069523 | 1.71 | 70.3 | Palliative (P) | 2019-07-14 | 2020-03-13 | BRIGATINIB | N | N | CYTARABINE + METHOTREXATE | 101547218 |
| 10413699 | 10069524 | 1.67 | 90 | Palliative (P) | 2017-05-08 | 2019-12-03 | null | 02 | N | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 100958792 |
| 10417622 | 10069526 | 1.75 | 0 | null | 2021-02-23 | 2021-02-26 | Bortezomib + Panobinostat + Thalidomide | null | null | ISATUXIMAB + POMALIDOMIDE | 101605680 |
| 10421790 | 10069527 | 1.55 | 69.5 | null | 2009-12-10 | 2019-08-25 | Pemetrexed | 02 | null | BEXAROTENE | 100885565 |
| 10431345 | 10069530 | 1.7 | 68.4 | null | 2017-12-18 | 2017-12-18 | ALEMTUZUMAB + PENTOSTATIN | 02 | null | EVEROLIMUS | 101540212 |
| 10432764 | 10069531 | 1.7 | 92 | null | null | 2018-07-21 | null | 02 | null | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 101502651 |
| 10458298 | 10069538 | 1.82 | 71.6 | null | 2020-06-15 | 2020-06-29 | ABEMACICLIB + FULVESTRANT | 99 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101103577 |
| 10464834 | 10069543 | 1.75 | 64.55 | null | 2022-03-30 | 2022-04-02 | null | 02 | null | BLEOMYCIN | 100372596 |
| 10475356 | 10069547 | 1.59 | 93 | null | 2019-08-28 | 2019-09-21 | OSIMERTINIB | 02 | null | DURVALUMAB | 100693937 |
| 10480687 | 10069550 | 1.77 | 71.75 | Palliative (P) | null | 2022-02-16 | Capecitabine + Cisplatin | 02 | N | EXEMESTANE + PALBOCICLIB | 101792844 |
| 10293097 | 10069557 | null | null | 03 | 2020-09-03 | 2020-10-17 | MATRIX (lymphoma) | 02 | N | IDELALISIB + RITUXIMAB | 100052121 |
| 10330421 | 10069559 | 0 | 80 | null | null | 2021-10-16 | ABVD | 02 | null | RCD TRIAL | 100171223 |
| 10349659 | 10069561 | 1.83 | 74.4 | Palliative (P) | 2018-11-06 | 2019-07-15 | CHLORAMBUCIL + OFATUMUMAB | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100533354 |
| 10410151 | 10069563 | 1.81 | 64 | null | 2018-12-27 | 2019-11-26 | ISATUXIMAB + POMALIDOMIDE | 02 | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100800127 |
| 10457743 | 10069565 | 1.69 | 75.2 | null | 2021-12-05 | 2022-04-10 | Pemetrexed | 02 | null | MITOMYCIN INTRAVESICULAR | 100085056 |
| 10408405 | 10070212 | 1.82 | 87.9 | Adjuvant (A) | 2020-09-21 | 2020-09-21 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | RITUXIMAB | 100679047 |
| 10408518 | 10070213 | null | 103.9 | null | 2022-04-16 | 2022-04-16 | IBRUTINIB | 02 | null | IBRUTINIB | 101311923 |
| 10408762 | 10070214 | 1.66 | 85 | null | 2017-07-22 | 2017-07-29 | IBRUTINIB | null | null | IBRUTINIB | 100821930 |
| 10408772 | 10070215 | 1.72 | 76 | null | 2021-05-07 | 2021-05-07 | IBRUTINIB | null | null | IBRUTINIB | 100905501 |
| 10408775 | 10070216 | 1.73 | 72.6 | null | 2022-01-09 | 2022-03-11 | IBRUTINIB | 02 | null | IBRUTINIB | 100375278 |
| 10408911 | 10070217 | 1.72 | 90 | null | 2020-08-11 | 2020-08-11 | IBRUTINIB | null | null | IBRUTINIB | 100555273 |
| 10408983 | 10070218 | 1.83 | 61.3 | null | 2021-08-12 | 2021-08-13 | IBRUTINIB | 02 | null | RITUXIMAB | 100580147 |
| 10409103 | 10070219 | 0 | null | null | 2019-08-21 | 2019-08-21 | IBRUTINIB | 02 | null | IBRUTINIB | 101352618 |
| 10409256 | 10070221 | 1.67 | 66 | null | 2019-07-09 | 2019-07-13 | IBRUTINIB | 02 | null | IBRUTINIB | 101009849 |
| 10409262 | 10070222 | 0 | 78.8 | Palliative (P) | 2021-10-18 | 2021-10-22 | Rituximab | 02 | N | RITUXIMAB | 100264734 |
| 10409861 | 10070226 | 1.65 | 75.1 | null | 2021-06-01 | 2022-05-07 | IBRUTINIB | 02 | null | IBRUTINIB | 100342851 |
| 10409900 | 10070227 | 1.65 | null | Palliative (P) | null | 2020-01-08 | IBRUTINIB | 02 | N | IBRUTINIB | 100729963 |
| 10409928 | 10070228 | null | 62 | Palliative (P) | 2018-03-12 | 2018-06-29 | IBRUTINIB | 02 | N | IBRUTINIB | 100358247 |
| 10409983 | 10070229 | 0 | 70 | null | 2021-04-17 | 2021-04-19 | IBRUTINIB | 02 | null | IBRUTINIB | 101572274 |
| 10410087 | 10070230 | 1.87 | 68.8 | null | 2017-04-15 | 2017-07-09 | IBRUTINIB | 02 | null | IBRUTINIB | 100557670 |
| 10410111 | 10070231 | null | 68.3 | null | 2017-01-18 | 2017-07-01 | Rituximab | 02 | null | RITUXIMAB | 100391285 |
| 10410140 | 10070232 | 1.75 | 62 | null | 2021-01-10 | 2021-01-10 | IBRUTINIB | 02 | null | IBRUTINIB | 100826318 |
| 10410194 | 10070233 | 1.68 | 95.2 | null | 2017-06-15 | 2020-06-25 | IBRUTINIB | 02 | null | IBRUTINIB | 101714922 |
| 10410197 | 10070234 | 0 | 97.8 | null | 2016-05-31 | 2019-03-15 | IBRUTINIB | 02 | null | IBRUTINIB | 101365329 |
| 10410291 | 10070235 | 1.76 | 0 | null | 2017-01-16 | 2020-05-13 | IBRUTINIB | 02 | null | IBRUTINIB | 100933310 |
| 10410297 | 10070236 | null | 75.1 | 03 | 2022-01-08 | 2022-01-08 | IBRUTINIB | 02 | N | IBRUTINIB | 100358546 |
| 10410456 | 10070237 | 1.84 | null | null | 2021-01-04 | 2021-01-05 | IBRUTINIB | N | null | IBRUTINIB | 101253923 |
| 10410462 | 10070238 | 1.73 | 52.5 | null | null | null | IBRUTINIB | 02 | null | IBRUTINIB | 101428947 |
| 10410816 | 10070240 | 1.59 | null | 03 | 2018-11-08 | 2018-11-09 | Rituximab | 02 | N | RITUXIMAB | 101542208 |
| 10410826 | 10070241 | 1.58 | 62 | null | 2021-03-26 | 2021-03-27 | IBRUTINIB | 02 | null | IBRUTINIB | 100340663 |
| 10410998 | 10070242 | 1.7 | 0 | null | 2020-07-21 | 2020-08-26 | IBRUTINIB | 02 | null | IBRUTINIB | 100025213 |